Align Technology, Inc. (ALGN)
After hours:
| Previous close | 309.50 |
| Open | 305.70 |
| Bid | 296.68 x 800 |
| Ask | 307.63 x 800 |
| Day's range | 298.88 - 305.70 |
| 52-week range | 172.05 - 413.20 |
| Volume | |
| Avg. volume | 698,539 |
| Market cap | 22.982B |
| Beta (5Y monthly) | 1.63 |
| PE ratio (TTM) | 75.83 |
| EPS (TTM) | 3.96 |
| Earnings date | 25 Oct 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 397.92 |
Business WireAlign Technology Connects With Over 1,000 Doctors and Practice Staff at the 2023 Invisalign™ GP Summit Where Leaders in Digital Orthodontics and Restorative Dentistry Share Best Practices for Leading Transformation in Dentistry
LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz., September 19, 2023--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from the 2023 Invisalign GP Summit, the Company’s premier clinical education and networking experience designed to help doctors transfor
ZacksAre Medical Stocks Lagging Brainsway (BWAY) This Year?
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Align Technology (ALGN) have performed compared to their sector so far this year.
ZacksHere's Why Align Technology (ALGN) is Poised for a Turnaround After Losing -10.74% in 4 Weeks
Align Technology (ALGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
